Skip to main content
Contact Us
Subscribe
e-Edition
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
62°
Clear
Site search
Menu
Subscribe
Home
News
Local News
Sports
Obituaries
e-Edition
Classifieds
Real Estate
Property For Rent
Cars & Vehicles
Jobs
Items For Sale
Pets
Auctions, Estate & Garage Sales
Services
Community
Personals
Place An Ad
Explore the Sheyenne
Archives
Best of 2025
Symbols
Recent Quotes
Organogenesis Holdings Inc. - Class A
ProShares Large Cap Core Plus
Viking Therapeutics, Inc. - Common Stock
WSFS Financial Corporation - Common Stock
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Viking Therapeutics, Inc. - Common Stock
(NQ:
VKTX
)
24.36
0.00 (0.00%)
Streaming Delayed Price
8:00:01 PM GMT, Aug 19, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Viking Therapeutics, Inc. - Common Stock
< Previous
1
2
3
4
5
6
7
8
9
...
26
27
Next >
Eli Lilly Stock Marks Worst Day In 25 Years As Weight-Loss Pill Data Disappoints: Analysts Divided But Retail Bets On Rebound
August 07, 2025
Via
Stocktwits
Eli Lilly Shares Tumble After Disappointing Weight-Loss Pill Data
August 07, 2025
Indianapolis, IN – Shares of pharmaceutical giant Eli Lilly and Company (NYSE: LLY) experienced a dramatic decline today, plummeting by more than 14% in early trading, wiping out approximately $98...
Via
MarketMinute
Eli Lilly Shares Tumble as Oral Weight-Loss Hope Falls Short of Lofty Expectations
August 07, 2025
Indianapolis, IN – Shares of pharmaceutical giant Eli Lilly and Company (NYSE: LLY) experienced a significant downturn, plummeting over 10% in premarket trading and continuing to slide throughout the...
Via
MarketMinute
Topics
Economy
Earnings Scheduled For July 23, 2025
July 23, 2025
Via
Benzinga
A Look Ahead: Viking Therapeutics's Earnings Forecast
July 22, 2025
Via
Benzinga
Eli Lilly's Rare Weight Loss Data Miss Could Benefit Competitors
August 07, 2025
Eli Lilly's obesity drug data misses targets, boosting shares of Novo Nordisk, Viking, Structure, and Terns amid promising trial updates.
Via
Benzinga
Lilly Skids On A Shocking Obesity Setback. Novo, Viking, Structure Surge.
August 07, 2025
An analyst called the unexpected flop a "once-in-a-blue-moon" occasion for Eli Lilly's dominant weight-loss franchise.
Via
Investor's Business Daily
Is It Time to Buy Biotech Stocks?
August 06, 2025
A surge in private market investment has investors wondering: Is it time to bet bigger on biotech?
Via
The Motley Fool
This Biotech Stock Could Soar on Upcoming Clinical Data
August 04, 2025
This weight loss drugmaker may be significantly undervalued right now.
Via
The Motley Fool
2 Beaten-Down Stocks With Incredible Upside Potential
August 03, 2025
Getting in on the ground floor with these companies might lead to superior returns.
Via
The Motley Fool
2 Biotech Stocks That Could Soar 29% and 165% According to Wall Street's Top Analysts
August 03, 2025
These biotech businesses look compelling for very different reasons.
Via
The Motley Fool
Is Viking Therapeutics the Next Big Biotech Bet?
August 01, 2025
Via
The Motley Fool
Benzinga Bulls And Bears: T-Mobile, LendingTree, Molina Healthcare — And Trade Deal Optimism Boosts Markets
July 26, 2025
Benzinga examined the prospects for many investors' favorite stocks over the last week — here's a look at some of our top stories.
Via
Benzinga
Tesla Posts Downbeat Earnings, Joins Community Health Systems, Chipotle Mexican Grill And Other Big Stocks Moving Lower In Thursday's Pre-Market Session
July 24, 2025
Via
Benzinga
Viking Therapeutics Posts Wider Q2 Loss
July 23, 2025
Via
The Motley Fool
Viking Therapeutics Stock Slides After Company Misses Q2 Earnings Estimates
July 23, 2025
Viking Therapeutics shares fall in Wednesday's after-hours session after the company reported financial results for the second quarter.
Via
Benzinga
Viking (VKTX) Q2 2025 Earnings Call Transcript
July 23, 2025
Via
The Motley Fool
Topics
Earnings
Intellectual Property
12 Health Care Stocks Moving In Wednesday's After-Market Session
July 23, 2025
Via
Benzinga
Viking Therapeutics Inc (NASDAQ:VKTX) Posts Wider Q2 2025 Loss, Shares Drop in After-Hours Trading
July 23, 2025
Viking Therapeutics reports wider Q2 2025 loss, missing EPS estimates, causing a 5.7% after-hours dip. Focus remains on clinical pipeline progress amid revenue challenges.
Via
Chartmill
Better Growth Buy: Eli Lilly vs. Viking Therapeutics
July 22, 2025
Via
The Motley Fool
3 Monster Stocks in the Making to Buy Right Now
July 21, 2025
Via
The Motley Fool
These 2 Stocks Could More Than Double Your Money, According to Wall Street. Is It Time to Buy?
July 20, 2025
Via
The Motley Fool
After Falling 68%, Where Will This Weight-Loss Drug Stock Be in 2 Years? History Shows Massive Gains Ahead.
July 19, 2025
Yet another biopharma name has been run through a familiar trading cycle that often ends on a bullish note.
Via
The Motley Fool
Topics
Intellectual Property
The Best Stocks to Invest $1,000 In Right Now
July 15, 2025
Via
The Motley Fool
Topics
Artificial Intelligence
Economy
Better Growth Buy: Eli Lilly vs. Viking Therapeutics
July 07, 2025
Via
The Motley Fool
Why I Think Viking Therapeutics Is an Asymmetric Growth Opportunity
July 04, 2025
Via
The Motley Fool
Topics
Artificial Intelligence
2 Beaten-Down Stocks With Massive Upside Potential
July 03, 2025
Via
The Motley Fool
10 Incredible Growth Stocks Poised for Long-Term Gains
July 02, 2025
Via
The Motley Fool
Topics
Artificial Intelligence
Got $200? 2 Biotech Stocks to Buy and Hold Forever
July 01, 2025
Via
The Motley Fool
Can Protagonist Take On Eli Lilly's Next-Generation Obesity Treatment?
June 30, 2025
The company announced a new drug that uses the same mechanism as Eli Lilly's retatrutide.
Via
Investor's Business Daily
< Previous
1
2
3
4
5
6
7
8
9
...
26
27
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms Of Service
.